Latest News about AZN
Recent news which mentions AZN
   Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
   
  
  
  October 04, 2024
  From Benzinga
 
   AstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority Review
   
  
  
  October 03, 2024
  From Benzinga
 
   US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
   
  
  
  October 01, 2024
  From Benzinga
 
   AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
   
  
  
  September 26, 2024
  From Benzinga
 
   Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
   
  
  
  September 23, 2024
  From Benzinga
 
   Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients
   
  
  
  September 23, 2024
  From Benzinga
 From Motley Fool
 
   Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
   
  
  
  September 18, 2024
  From Benzinga
 
   AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
   
  
  
  September 18, 2024
  From Benzinga
 
   AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
   
  
  
  September 10, 2024
  From Benzinga
 
   AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
   
  
  
  September 10, 2024
  From Benzinga
 
   Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
   
  
  
  September 09, 2024
  From Benzinga
 
   3 Market-Beating Stocks to Buy for Less Than $100
   
  
  
  September 06, 2024
  From Motley Fool
 From Benzinga
 
   AstraZeneca Options Trading: A Deep Dive into Market Sentiment
   
  September 05, 2024
  Tickers 
   AZN
  
  
  From Benzinga
 
   EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
   
  
  
  September 04, 2024
  From Benzinga
 
   Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
   
  
  
  September 03, 2024
  From Benzinga
 From Benzinga
 
   Ozempic And Wegovy Linked to Increased Suicidal Thoughts In Observational Study, But Results Are Contested
   
  
  
  August 20, 2024
  From Benzinga
 From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  August 19, 2024
  From Benzinga
 
   FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
   
  
  
  August 16, 2024
  From Benzinga
 From Benzinga
 From InvestorPlace
 From Benzinga
 
   New European Regulations Could Hinder Rare Disease Treatments, Pharma Industry Raises Concerns Over Stricter Clinical Trial Rules
   
  
  
  August 13, 2024
  From Benzinga
 
   Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
   
  
  
  August 13, 2024
  From Benzinga
 
   EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
   
  
  
  August 08, 2024
  From Benzinga
 
   Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
   
  
  
  August 05, 2024
  From Benzinga
 Tickers 
   AZN
  
  
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
